<DOC>
	<DOCNO>NCT01225575</DOCNO>
	<brief_summary>This prospective , randomise , open label , multicentre Phase II clinical trial investigate efficacy safety treatment large defect 3 different dos autologous chondrocyte transplantation product co.don chondrosphere® ( ACT3D-CS ) subject cartilage defect knee . After screen visit patient book arthroscopy cell harvest healthy cartilage . After arthroscopy patient randomise one three dose-groups . The cell cultivate 8-10 week vitro develope 3-dimensional spheroid , transplant open knee procedure ( treatment surgery ) defect . Patients dose group subsequently follow rehabilitation program post-surgery visit . The 12-month-visit defined final assessment . Then patient follow-up assessment 60 month .</brief_summary>
	<brief_title>Assessment Efficacy Safety 3 Different Doses co.Don Chondrosphere Treat Large Cartilage Defects</brief_title>
	<detailed_description>see</detailed_description>
	<criteria>1 . Male female patient , age : 18 50 year 2 . Defect : isolated ICRS grade III IV single defect medial lateral femoral condyle , trochlea , tibia retropatellar defect , also OCD ( case OCD : Bone graft level original bone lamella must perform bone loss exceed 3 mm depth ) 3 . Defect size : ≥ 4 10 cm2 debridement healthy cartilage ; chondral lesion , include osteochondritis dissecans femoral condyle , trochlea , tibia , retropatellar defect 6 mm depth . Assessment MRI Screening per estimation arthroscopy prior randomization 4 . Nearly intact surround chondral structure around defect well correspond joint area 5 . Informed consent sign patient 6 . Patient understands strict rehabilitation protocol followup programme willing follow . 7 . In case pain , patient agrees use paracetamol mono ( max 4 g/day ) combination preparation oral and/or topic NSAIDs trial discontinue use oral and/or topic NSAIDs and/or paracetamol combination preparation 1 week visit whereas use paracetamol monopreparation ( max 4 g/day ) allow . However , morning visit day , pain medication allow . However , morning visit day , pain medication allow . Other pain medication allow surgical operation may take period exceed 4 week surgery . 1 . Defects knees time 2 . Radiological sign osteoarthritis 3 . Any sign knee instability 4 . Valgus varus malalignment ( 5° mechanical axis ) 5 . Clinically relevant second cartilage lesion knee 6 . More 50 % resection meniscus affect knee incomplete meniscal rim 7 . Rheumatoid arthritis , parainfectious infectious arthritis , condition disease 8 . Pregnancy plan pregnancy ( MRI possible ) 9 . Obesity ( Body Mass Index &gt; 30 ) 10 . Uncontrolled diabetes mellitus 11 . Serious illness 12 . Poor general health judge physician 13 . Participation concurrent clinical trial previous trial within 3 month screen 14 . Previous treatment ACT affect knee 15 . Microfracture perform less 1 year screening affect knee 16 . Alcohol drug ( medication ) abuse 17 . Meniscal transplant affect knee 18 . Meniscal suture ( affected knee ) three month prior baseline 19 . Mosaicplasty ( Osteoarticular Transplant System , OATS ) affect knee 20 . Having receive hyaluronic acid intraarticular injection affect knee within last 3 month baseline 21 . Taking specific osteoarthritis drug chondroitin sulfate , diacerein , nglucosamine , piascledine , capsaicin within 2 week baseline 22 . Corticosteroid treatment systemic intraarticular route within last month baseline intramuscular oral corticosteroid within last 2 week baseline 23 . Chronic use anticoagulant 24 . Any concomitant painful disable disease spine , hip low limb would interfere evaluation afflict knee 25 . Any clinically significant symptomatic vascular neurological disorder low extremities 26 . Any evidence follow disease affect knee : septic arthritis , inflammatory joint disease , recurrent episode pseudogout , Paget 's disease bone , ochronosis , acromegaly , haemochromatosis , Wilson 's disease , primary osteochondromatosis , heritable disorder , collagen gene mutation 27 . Current diagnosis osteomyelitis , human immunodeficiency virus ( HIV1 , 2 ) and/or hepatitis C ( HCV ) infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>large cartilage defect</keyword>
	<keyword>knee joint</keyword>
	<keyword>femoral condyle , tibia , trochlear , retropatellar</keyword>
</DOC>